Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

8.1%

3 terminated out of 37 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

14%

5 trials in Phase 3/4

Results Transparency

83%

5 of 6 completed with results

Key Signals

5 with results67% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (20)
Early P 1 (1)
P 2 (8)
P 3 (4)
P 4 (1)

Trial Status

Recruiting13
Active Not Recruiting10
Completed6
Withdrawn3
Terminated3
Not Yet Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT03899987Phase 2Active Not Recruiting

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

NCT06733350Phase 4Recruiting

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

NCT04530552Phase 2Active Not Recruiting

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

NCT04215029Not ApplicableActive Not Recruiting

Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans

NCT04985565Not ApplicableActive Not Recruiting

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

NCT06325046Not ApplicableRecruiting

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

NCT07468903Not ApplicableNot Yet Recruiting

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

NCT04624256Not ApplicableActive Not Recruiting

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

NCT03575832Not ApplicableActive Not Recruiting

Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners

NCT05320406Phase 2Active Not Recruiting

RElugolix VErsus LeUprolide Cardiac Trial

NCT07276438Not ApplicableRecruiting

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

NCT04981834Not ApplicableSuspended

Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer

NCT05838716Phase 3Recruiting

Vitamin D for Prostate Endocrine Therapy

NCT04134260Phase 3Recruiting

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

NCT04189770Active Not Recruiting

Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners

NCT06016725Not ApplicableCompleted

Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial

NCT02600156Not ApplicableCompleted

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

NCT04501913Completed

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

NCT06500169Not ApplicableRecruiting

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

NCT03987386Phase 3Active Not Recruiting

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Scroll to load more

Research Network

Activity Timeline